<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01409330</url>
  </required_header>
  <id_info>
    <org_study_id>DDIET3521</org_study_id>
    <nct_id>NCT01409330</nct_id>
  </id_info>
  <brief_title>German Diabetes-Diet-Intervention and Energy Restriction-Trial (DDIET)</brief_title>
  <acronym>DDIET</acronym>
  <official_title>Short Term Diet Intervention in Newly Diagnosed Type 2 Diabetes. a Randomised, Multicentric, Controlled, Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>German Diabetes Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>German Diabetes Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Diet intervention according to the German Diabetes Risk Score in newly diagnosed type 2
      diabetes.

      This study aims to explore the effect of diet lacking red meat, but containing increased
      fibers and coffee (verum) versus standard recommendation (control) in a multicenter setting.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a randomised, multicenter controlled trial Our Aim is to test the effects of an
      8-week diet lacking red meat, containing increased fibers and coffee (verum) versus standard
      recommendation (control)in a multicenter setting.

      We are expecting that the verum diet will improve insulin sensitivity and insulin secretion
      due to reductions in visceral and hepatic fat along with improved adipocyte cytokine
      secretion profiles
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2011</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">September 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>whole body insulin sensitivity</measure>
    <time_frame>8 weeks</time_frame>
    <description>measurement of whole body insulin sensitivity with hyperinsulinamic euglicamic clamp</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>total body fat</measure>
    <time_frame>8 weeks</time_frame>
    <description>MRI measurement of the effects of 8-week diet intervention on total body fat</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>intramyocellular lipids</measure>
    <time_frame>8 weeks</time_frame>
    <description>MRS measurement to investigate the effects of diet intervention on ectopic lipid content in skeletal muscle</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>skeletal muscle mitochondrial function</measure>
    <time_frame>8 weeks</time_frame>
    <description>muscle biopsy for assessment of insulin signaling</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hepatocellular lipids</measure>
    <time_frame>8 weeks</time_frame>
    <description>MRS measurement to investigate the effects of diet intervention on ectopic lipid content in liver(HCL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>skeletal muscle mitochondrial function</measure>
    <time_frame>8 weeks</time_frame>
    <description>skeletal muscle mitochondrial function in vivo assessed as phosphate-recovery time with MRS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>insulin secretion</measure>
    <time_frame>8 weeks</time_frame>
    <description>measurement of insulin secretion with glucagon test, mixed-meal test and intravenous glucose tolerance test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pancreatic fat</measure>
    <time_frame>8 weeks</time_frame>
    <description>MRI measurement of the effects of 8-week diet intervention on pancreatic fat</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>hypocaloric diet containing increased fibers and coffee</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In the intervention group the patients are allowed to eat only white meat and fish. They also need to increase their daily fiber intake to 50grams and drink 5 cups of coffee a day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>hypocaloric diet containing red meat</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>control group (n=20): diet according to the ADA/EASD guidelines (50% carbohydrates, 20% proteins, 30% fat). In the control group the patients should eat 150 grams of red meat a day and are not allowed to consume alcohol, coffee and whole grains.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>diet intervention</intervention_name>
    <description>8-week diet lacking red meat, but containing increased fibers and coffee (verum) versus standard recommendation (control) eating red meat.</description>
    <arm_group_label>hypocaloric diet containing increased fibers and coffee</arm_group_label>
    <arm_group_label>hypocaloric diet containing red meat</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 2 diabetic patients

          -  disease duration for five years or less,

          -  age of 69 years or less,

          -  body mass index of 30 kg/m2 or more,

          -  hemoglobin A1c of 5,5 % to 9%

          -  patient should be on standard diet or metformin +/- acarbose monotherapy

          -  patient should be without exclusion criteria for coffee consumption

        Exclusion Criteria:

          -  disease duration more than five years,

          -  age of &gt; 69 years,

          -  body mass index of &lt; 30 kg/m2,

          -  hemoglobin A1c &lt; 5,5 % or &gt; 9%

          -  if patient becomes insulin therapy

          -  if patient has exclusion criteria for coffee consumption

          -  if patient is non-compliant with study protocol

          -  if patient is pregnant

          -  if patient has acute infection

          -  if patient has anaemia

          -  if patient has malignancies

          -  if patient has autoimmune or immune compromising diseases including HIV/AIDS

          -  if patient has psychiatric diseases or addiction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Roden, Professor, MD</last_name>
    <role>Study Director</role>
    <affiliation>German Diabetes Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lejla Zahiragic, MD</last_name>
    <phone>00492118104819</phone>
    <phone_ext>319</phone_ext>
    <email>lejla.zahiragic@med.uni-duesseldorf.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bettina Nowotny, MD, M.Sc.</last_name>
    <phone>00492113382575</phone>
    <email>studienzentrum@ddz.uni-duesseldorf.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>German Diabetes Center</name>
      <address>
        <city>Duesseldorf</city>
        <state>NRW</state>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lejla Zahiragic, MD</last_name>
      <phone>00492118104819</phone>
      <email>lejla.zahiragic@med.uni-duesseldorf.de</email>
    </contact>
    <contact_backup>
      <last_name>Bettina Nowotny, MD</last_name>
      <phone>00492113382-0</phone>
      <phone_ext>-575</phone_ext>
      <email>bettina.nowotny@ddz.uni-duesseldorf.de</email>
    </contact_backup>
    <investigator>
      <last_name>Lejla Zahiragic, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bettina Nowotny, MD, M.Sc.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Roden, Professor, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Charite, Department of Internal Medicine</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospital, Department of Internal Medicine III</name>
      <address>
        <city>Dresden</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ulrike Schatz, MD</last_name>
    </contact>
    <investigator>
      <last_name>Ulrike Schatz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stefan Bornstein, Professor, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital, Department of Internal Medicine I</name>
      <address>
        <city>Heidelberg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Groener, MD</last_name>
      <email>jan.groener@med.uni-heidelberg.de</email>
    </contact>
    <investigator>
      <last_name>Jan Groener, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Peter Nawroth, Professor, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum der Universität München (KUM)</name>
      <address>
        <city>Munich</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospital, Department of Internal Medicine IV</name>
      <address>
        <city>Tübingen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 8, 2011</study_first_submitted>
  <study_first_submitted_qc>August 3, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 4, 2011</study_first_posted>
  <last_update_submitted>August 21, 2012</last_update_submitted>
  <last_update_submitted_qc>August 21, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 22, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>insulin sensitivity</keyword>
  <keyword>type 2 diabetes</keyword>
  <keyword>diet intervention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

